CASI Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $25.7M
Liabilities Breakdown FY2025
Total Liabilities: $62.9M
Asset Breakdown
Total Assets: $25.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.6M | 22.0% |
| Accounts Receivable | $4.1M | 16.0% |
| Inventory | $1.6M | 6.2% |
| Property, Plant & Equipment | $7.0M | 27.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $221.0K | 0.9% |
| Other Assets | $7.1M | 27.8% |
Liabilities Breakdown
Total Liabilities: $62.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 1.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $61.9M | 98.3% |